Positive News Sentiment NASDAQ:XXII 22nd Century Group - XXII Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding 22nd Century Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. $1.07 -0.03 (-2.73%) (As of 02/1/2023 12:00 AM ET) Add Compare Share Share Today's Range$1.04▼$1.1050-Day Range$0.82▼$1.2152-Week Range$0.82▼$2.71Volume1.24 million shsAverage Volume1.08 million shsMarket Capitalization$230.37 millionP/E RatioN/ADividend YieldN/APrice Target$5.00 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media 22nd Century Group MarketRank™ ForecastAnalyst RatingBuy3.00 Rating ScoreUpside/Downside367.3% Upside$5.00 Price TargetShort InterestBearish7.42% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews SentimentN/AInsider TradingN/AProj. Earnings GrowthGrowingFrom ($0.24) to ($0.21) Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.1.89 out of 5 starsConsumer Staples Sector105th out of 140 stocksCigarettes Industry4th out of 5 stocks 3.5 Analyst's Opinion Consensus Rating22nd Century Group has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $5.00, 22nd Century Group has a forecasted upside of 367.3% from its current price of $1.07.Amount of Analyst Coverage22nd Century Group has only been the subject of 1 research reports in the past 90 days. Previous Next 2.0 Short Interest Percentage of Shares Shorted7.42% of the outstanding shares of 22nd Century Group have been sold short.Short Interest Ratio / Days to Cover22nd Century Group has a short interest ratio ("days to cover") of 11.8, which indicates bearish sentiment.Change versus previous monthShort interest in 22nd Century Group has recently decreased by 5.33%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend Yield22nd Century Group does not currently pay a dividend.Dividend Growth22nd Century Group does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for XXII. Previous Next 3.3 News and Social Media Coverage News Sentiment22nd Century Group has a news sentiment score of 1.89. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.60 average news sentiment score of Consumer Staples companies.Search Interest14 people have searched for XXII on MarketBeat in the last 30 days. This is an increase of 56% compared to the previous 30 days.MarketBeat FollowsOnly 8 people have added 22nd Century Group to their MarketBeat watchlist in the last 30 days. This is a decrease of -11% compared to the previous 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, 22nd Century Group insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 2.40% of the stock of 22nd Century Group is held by insiders.Percentage Held by InstitutionsOnly 20.63% of the stock of 22nd Century Group is held by institutions. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for 22nd Century Group are expected to grow in the coming year, from ($0.24) to ($0.21) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of 22nd Century Group is -4.12, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of 22nd Century Group is -4.12, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share Ratio22nd Century Group has a P/B Ratio of 2.61. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About 22nd Century Group (NASDAQ:XXII) Stock22nd Century Group, Inc. is a biotechnology company, which develops disruptive plant-based solutions the for life science, consumer product, and pharmaceutical markets. It focuses on technologies that alter the level of nicotine in tobacco plants and the level of cannabinoids in hemp or cannabis plants through genetic engineering, gene-editing, and modern plant breeding techniques. The company was founded on September 12, 2005 and is headquartered in Buffalo, NY.Read More Receive XXII Stock News and Ratings via Email Sign-up to receive the latest news and ratings for 22nd Century Group and its competitors with MarketBeat's FREE daily newsletter. Email Address XXII Stock News HeadlinesJanuary 23, 2023 | finance.yahoo.com22nd Century Group (XXII) Announces Filing of U.S. DMF (Drug Master File) for CBD API; New Global Sales, Marketing and Distribution Agreement with Transo-Pharm for Cannabinoid APIsJanuary 18, 2023 | finance.yahoo.com22nd Century Group (XXII) Announces U.S. Distribution Partnerships with Core-Mark and Eby-BrownFebruary 2, 2023 | Investor Place Media (Ad)Cash Holders STILL Aren't Taking Steps to PrepareStocks are crashing... inflation is through the roof... multiple industries are getting hit hard... Americans are fearful of what might happen to their stock portfolios right now -- and who's to blame them? But former Wall Street money manager Louis Navellier says all it takes is being on the right side of this force driving the massive divide. Take action today and watch his exclusive presentation -- absolutely free of charge -- to see how you should be prepping for this phenomenon.January 17, 2023 | finance.yahoo.comFDA's Proposed Menthol Ban Advances to Final Rule Status, Greatly Benefits 22nd Century (XXII) by Affirming the Need for VLN(R) Menthol King as a Critical Off-Ramp for Adult Menthol SmokersDecember 28, 2022 | msn.com12 Consumer Staples Stocks Moving In Wednesday's After-Market SessionDecember 13, 2022 | finance.yahoo.com22nd Century Group (XXII) Comments on the Advancement of New Zealand's National Reduced Nicotine Content LawDecember 8, 2022 | finance.yahoo.com22nd Century Group Provides Update on Grass Valley FacilityDecember 5, 2022 | msn.com22nd Century Group Earnings Perspective: Return On Capital EmployedFebruary 2, 2023 | Tradewins (Ad)Know Your Profit Potential BEFORE You Trade!I’m Chuck Hughes, ten-time trading champion and author of the coveted e-book, “Options Trading Made Easy”, the strategy guide that will teach you to calculate your trade’s profit potential before you risk any capital. Click here for a free copy now! November 21, 2022 | finance.yahoo.com22nd Century Group Provides Update on Incident at Grass Valley FacilityNovember 17, 2022 | finance.yahoo.com22nd Century Group had a big year. The FDA could make 2023 even bigger.November 16, 2022 | seekingalpha.com22nd Century Group Could Turn Profitable In 2023November 15, 2022 | finance.yahoo.com22nd Century Group (Nasdaq: XXII) GVB Biopharma to Exhibit at MJBizCon in Las VegasNovember 9, 2022 | seekingalpha.com22nd Century Group, Inc. (XXII) Q3 2022 Earnings Call TranscriptNovember 8, 2022 | benzinga.com22nd Century Group Q3 Revenue Grows 148% YoY, Here Are The DetailsNovember 8, 2022 | finance.yahoo.com22nd Century Group (Nasdaq: XXII) Reports Business Highlights and Financial Results for the Third Quarter 2022November 7, 2022 | technews.tmcnet.comNew Study Again Shows 22nd Century's Reduced Nicotine Content Cigarettes Reduce Cigarette Consumption and Increase Smoking CessationNovember 7, 2022 | finance.yahoo.comNew Study Again Shows 22nd Century’s Reduced Nicotine Content Cigarettes Reduce Cigarette Consumption and Increase Smoking CessationOctober 27, 2022 | finance.yahoo.com22nd Century Group (Nasdaq: XXII) to Announce Third Quarter 2022 Results on November 8, 2022October 26, 2022 | finance.yahoo.com22nd Century Group (Nasdaq: XXII) to Expand VLN® Sales in Three Additional States: Arizona, Utah and New MexicoOctober 18, 2022 | finance.yahoo.com22nd Century Group (Nasdaq: XXII) to Present at LD Micro Conference on October 26October 16, 2022 | marketwatch.comThinking about buying stock in Imara, Nutanix, Azul, 22nd Century Group, or Altimmune?October 6, 2022 | finance.yahoo.comFirst Cigarette Authorized by FDA to “Help You Smoke Less” Now Available Across ColoradoOctober 5, 2022 | marketwatch.com22nd Century Group (Nasdaq: XXII) Expands VLN(R) Distributor Network with the Addition of Specialty Distributor Creager MercantileOctober 3, 2022 | finance.yahoo.com22nd Century Group (Nasdaq: XXII) Expands VLN® Distributor Network with the Addition of Specialty Distributor Creager MercantileSeptember 20, 2022 | finance.yahoo.com22nd Century Group (Nasdaq: XXII) Partners With Eagle Rock Distributing Company to Place VLN® in Thousands of Retail Locations Across ColoradoSeptember 13, 2022 | technews.tmcnet.com22nd Century Group's (Nasdaq: XXII) VLN® Cigarettes with Reduced Nicotine Technology Ready to Ignite Biden's Cancer Moonshot InitiativeSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive XXII Stock News and Ratings via Email Sign-up to receive the latest news and ratings for 22nd Century Group and its competitors with MarketBeat's FREE daily newsletter. Email Address XXII Company Calendar Last Earnings11/08/2022Today2/01/2023Next Earnings (Estimated)3/07/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Cigarettes Sub-IndustryCannabis SectorConsumer Staples Current SymbolNASDAQ:XXII Previous SymbolAMEX:XXII CUSIPN/A CIK1347858 Webwww.xxiicentury.com Phone(716) 270-1523Fax716-877-3064Employees76Year FoundedN/APrice Target and Rating Average Stock Price Forecast$5.00 High Stock Price Forecast$6.00 Low Stock Price Forecast$4.00 Forecasted Upside/Downside+367.3%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage3 Analysts Profitability EPS (Most Recent Fiscal Year)($0.26) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-32,610,000.00 Net Margins-93.35% Pretax Margin-98.40% Return on Equity-49.37% Return on Assets-42.10% Debt Debt-to-Equity RatioN/A Current Ratio3.45 Quick Ratio2.79 Sales & Book Value Annual Sales$30.95 million Price / Sales7.44 Cash FlowN/A Price / Cash FlowN/A Book Value$0.41 per share Price / Book2.61Miscellaneous Outstanding Shares215,300,000Free Float210,135,000Market Cap$230.37 million OptionableOptionable Beta1.87 Key ExecutivesJames A MishPresident, Chief Executive Officer & DirectorJohn J. MillerChief Operating Officer & President-TobaccoRobert Hugh KinsmanChief Financial OfficerJuan Sanchez TamburrinoVice President-Research & DevelopmentCalvin TreatChief Scientific OfficerKey CompetitorsCadizNASDAQ:CDZIMagnum Opus AcquisitionNYSE:OPAAlicoNASDAQ:ALCOLimoneiraNASDAQ:LMNRTupperware BrandsNYSE:TUPView All CompetitorsInsiders & InstitutionsAE Wealth Management LLCBought 39,767 shares on 1/31/2023Ownership: 0.024%International Assets Investment Management LLCBought 297,200 shares on 1/30/2023Ownership: 0.138%Sigma Planning CorpBought 42,100 shares on 1/24/2023Ownership: 0.059%Bank of New York Mellon CorpBought 44,287 shares on 12/8/2022Ownership: 0.262%Price T Rowe Associates Inc. MDBought 11,622 shares on 11/15/2022Ownership: 0.062%View All Insider TransactionsView All Institutional Transactions XXII Stock - Frequently Asked Questions Should I buy or sell 22nd Century Group stock right now? 3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for 22nd Century Group in the last twelve months. There are currently 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" XXII shares. View XXII analyst ratings or view top-rated stocks. What is 22nd Century Group's stock price forecast for 2023? 3 analysts have issued twelve-month price objectives for 22nd Century Group's stock. Their XXII share price forecasts range from $4.00 to $6.00. On average, they expect the company's stock price to reach $5.00 in the next year. This suggests a possible upside of 367.3% from the stock's current price. View analysts price targets for XXII or view top-rated stocks among Wall Street analysts. How have XXII shares performed in 2023? 22nd Century Group's stock was trading at $0.9205 at the beginning of 2023. Since then, XXII shares have increased by 16.2% and is now trading at $1.07. View the best growth stocks for 2023 here. When is 22nd Century Group's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, March 7th 2023. View our XXII earnings forecast. How were 22nd Century Group's earnings last quarter? 22nd Century Group, Inc. (NASDAQ:XXII) posted its quarterly earnings results on Tuesday, November, 8th. The biotechnology company reported ($0.06) earnings per share for the quarter, missing analysts' consensus estimates of ($0.05) by $0.01. The biotechnology company had revenue of $19.38 million for the quarter, compared to analyst estimates of $19.63 million. 22nd Century Group had a negative trailing twelve-month return on equity of 49.37% and a negative net margin of 93.35%. What other stocks do shareholders of 22nd Century Group own? Based on aggregate information from My MarketBeat watchlists, some companies that other 22nd Century Group investors own include Aurora Cannabis (ACB), Alteryx (AYX), Auxly Cannabis Group (CBWTF), Charlotte's Web (CWBHF), Enphase Energy (ENPH), Inseego (INSG), Luckin Coffee (LKNCY), MediPharm Labs (MEDIF) and MercadoLibre (MELI). What is 22nd Century Group's stock symbol? 22nd Century Group trades on the NASDAQ under the ticker symbol "XXII." Who are 22nd Century Group's major shareholders? 22nd Century Group's stock is owned by a variety of institutional and retail investors. Top institutional investors include International Assets Investment Management LLC (0.14%), Sigma Planning Corp (0.06%), AE Wealth Management LLC (0.02%) and Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include Clifford B Fleet, James A Mish, John Franzino, Michael Zercher, Nora B Sullivan and Roger D O'brien. View institutional ownership trends. How do I buy shares of 22nd Century Group? Shares of XXII stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is 22nd Century Group's stock price today? One share of XXII stock can currently be purchased for approximately $1.07. How much money does 22nd Century Group make? 22nd Century Group (NASDAQ:XXII) has a market capitalization of $230.37 million and generates $30.95 million in revenue each year. The biotechnology company earns $-32,610,000.00 in net income (profit) each year or ($0.26) on an earnings per share basis. How can I contact 22nd Century Group? 22nd Century Group's mailing address is 9530 Main St, CLARENCE, NY 14031-1915, United States. The official website for the company is www.xxiicentury.com. The biotechnology company can be reached via phone at (716) 270-1523, via email at investorrelations@xxiicentury.com, or via fax at 716-877-3064. This page (NASDAQ:XXII) was last updated on 2/2/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.